Scotia Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14M | Buy |
381,226
+61,064
| +19% | +$2.89M | 0.06% | 174 |
|
|
2025
Q4 | $16.3M | Buy |
320,162
+153,275
| +92% | +$7.84M | 0.07% | 158 |
|
|
2025
Q3 | $9.26M | Sell |
166,887
-24,460
| -13% | -$1.43M | 0.04% | 211 |
|
|
2025
Q2 | $13.2M | Sell |
191,347
-20,863
| -10% | -$1.42M | 0.06% | 165 |
|
|
2025
Q1 | $14.7M | Sell |
212,210
-73,581
| -26% | -$6.08M | 0.08% | 143 |
|
|
2024
Q4 | $24.6M | Buy |
285,791
+5,833
| +2% | +$631K | 0.13% | 97 |
|
|
2024
Q3 | $33.3M | Buy |
279,958
+31,462
| +13% | +$4.2M | 0.18% | 83 |
|
|
2024
Q2 | $35.5M | Buy |
248,496
+25,768
| +12% | +$3.41M | 0.21% | 72 |
|
|
2024
Q1 | $28.6M | Buy |
222,728
+17,204
| +8% | +$2.05M | 0.17% | 87 |
|
|
2023
Q4 | $21.3M | Buy |
205,524
+71,720
| +54% | +$7.09M | 0.14% | 101 |
|
|
2023
Q3 | $12.2M | Sell |
133,804
-4,834
| -3% | -$426K | 0.09% | 139 |
|
|
2023
Q2 | $11.2M | Sell |
138,638
-216
| -0.2% | -$17.6K | 0.08% | 149 |
|
|
2023
Q1 | $11M | Sell |
138,854
-20
| -0% | -$1.42K | 0.08% | 142 |
|
|
2022
Q4 | $9.4M | Sell |
138,874
-4,476
| -3% | -$262K | 0.07% | 156 |
|
|
2022
Q3 | $7.14M | Sell |
143,350
-710
| -0.5% | -$38K | 0.06% | 178 |
|
|
2022
Q2 | $8.03M | Sell |
144,060
-9,942
| -6% | -$552K | 0.06% | 172 |
|
|
2022
Q1 | $8.55M | Sell |
154,002
-8,496
| -5% | -$436K | 0.05% | 184 |
|
|
2021
Q4 | $9.1M | Buy |
162,498
+778
| +0.5% | +$42.1K | 0.06% | 178 |
|
|
2021
Q3 | $7.76M | Buy |
161,720
+7,984
| +5% | +$386K | 0.06% | 195 |
|
|
2021
Q2 | $6.44M | Buy |
153,736
+12,538
| +9% | +$486K | 0.05% | 217 |
|
|
2021
Q1 | $4.76M | Sell |
141,198
-1,308
| -0.9% | -$46.6K | 0.04% | 239 |
|
|
2020
Q4 | $4.98M | Sell |
142,506
-3,194
| -2% | -$110K | 0.05% | 211 |
|
|
2020
Q3 | $5.06M | Sell |
145,700
-498
| -0.3% | -$16.6K | 0.05% | 180 |
|
|
2020
Q2 | $4.81M | Sell |
146,198
-3,944
| -3% | -$126K | 0.07% | 157 |
|
|
2020
Q1 | $4.52M | Buy |
150,142
+1,810
| +1% | +$53.9K | 0.06% | 162 |
|
|
2019
Q4 | $4.29M | Sell |
148,332
-2,954
| -2% | -$81.8K | 0.05% | 193 |
|
|
2019
Q3 | $3.91M | Sell |
151,286
-7,938
| -5% | -$201K | 0.05% | 195 |
|
|
2019
Q2 | $4.07M | Sell |
159,224
-36,804
| -19% | -$910K | 0.05% | 191 |
|
|
2019
Q1 | $5.13M | Sell |
196,028
-65,814
| -25% | -$1.62M | 0.07% | 163 |
|
|
2018
Q4 | $6.03M | Sell |
261,842
-58,198
| -18% | -$1.29M | 0.09% | 139 |
|
|
2018
Q3 | $7.54M | Sell |
320,040
-35,656
| -10% | -$870K | 0.1% | 131 |
|
|
2018
Q2 | $8.69M | Sell |
355,696
-1,286
| -0.4% | -$30.6K | 0.12% | 113 |
|
|
2018
Q1 | $8.79M | Sell |
356,982
-7,168
| -2% | -$188K | 0.12% | 114 |
|
|
2017
Q4 | $9.77M | Sell |
364,150
-17,980
| -5% | -$457K | 0.13% | 112 |
|
|
2017
Q3 | $9.2M | Buy |
382,130
+48,370
| +14% | +$1.09M | 0.13% | 112 |
|
|
2017
Q2 | $7.16M | Buy |
333,760
+14,000
| +4% | +$283K | 0.12% | 118 |
|
|
2017
Q1 | $5.48M | Buy |
319,760
+15,044
| +5% | +$262K | 0.09% | 142 |
|
|
2016
Q4 | $5.47M | Sell |
304,716
-55,398
| -15% | -$1M | 0.09% | 155 |
|
|
2016
Q3 | $7.5M | Buy |
360,114
+67,472
| +23% | +$1.67M | 0.14% | 117 |
|
|
2016
Q2 | $7.87M | Buy |
292,642
+13,892
| +5% | +$381K | 0.16% | 105 |
|
|
2016
Q1 | $7.55M | Buy |
278,750
+93,322
| +50% | +$2.5M | 0.17% | 99 |
|
|
2015
Q4 | $5M | Hold |
185,428
| – | – | 0.11% | 150 |
|
|
2015
Q3 | $5.03M | Sell |
185,428
-102,408
| -36% | -$2.9M | 0.11% | 142 |
|
|
2015
Q2 | $7.85M | Buy |
287,836
+672
| +0.2% | +$18.9K | 0.16% | 113 |
|
|
2015
Q1 | $7.67M | Buy |
287,164
+4,886
| +2% | +$113K | 0.2% | 87 |
|
|
2014
Q4 | $5.97M | Sell |
282,278
-239,318
| -46% | -$5.35M | 0.16% | 94 |
|
|
2014
Q3 | $12.4M | Buy |
521,596
+2,046
| +0.4% | +$47.1K | 0.27% | 67 |
|
|
2014
Q2 | $12M | Sell |
519,550
-5,016
| -1% | -$111K | 0.26% | 67 |
|
|
2014
Q1 | $12M | Sell |
524,566
-66,394
| -11% | -$1.41M | 0.27% | 63 |
|
|
2013
Q4 | $10.9M | Buy |
590,960
+13,660
| +2% | +$238K | 0.26% | 65 |
|
|
2013
Q3 | $9.77M | Buy |
577,300
+300,540
| +109% | +$5.05M | 0.26% | 63 |
|
|
2013
Q2 | $4.29M | Buy |
+276,760
| New | +$4.61M | 0.17% | 93 |
|
Other funds holding NVO
DAM
F
Scotia Capital's NVO Position: Q1 2026 in Review
Scotia Capital increased its Novo Nordisk (NVO) stake by 19% in Q1 2026, buying an estimated $2.89M and bringing the position to 381,226 shares worth $14M. The position accounts for 0.06% of the portfolio, ranked #174.
Scotia Capital first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.5M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Scotia Capital held 381,226 shares of Novo Nordisk worth $14M as of Q1 2026.
- Scotia Capital bought 61,064 Novo Nordisk shares in Q1 2026, an estimated $2.89M.
- Novo Nordisk made up 0.06% of Scotia Capital's portfolio in Q1 2026, its #174 holding.
- Scotia Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
- Scotia Capital's Novo Nordisk position peaked at $35.5M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.